Company intelligence / Profile preview
MAAN Pharmaceuticals
Ahmedabad, Gujarat, Indiamaanpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MAAN Pharmaceuticals has a strong commercial presence in India and over 30 global markets with a focus on de-addiction therapies using buprenorphine and naltrexone formulations. The company also manufactures a broad range of generic pharmaceuticals including anti-infectives and vitamins. Pipeline includes depot injections of buprenorphine/naltrexone/naloxone for de-addiction treatment.
- Therapeutic areas
- Metabolic DisordersNeurologyPsychiatryWomen's HealthInfectious DiseasesHematologyOtherNephrologyCardiovascular
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on MAAN Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MAAN Pharmaceuticals.